El susto and the Mexican sugar tax
Publication date: Available online 19 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Talha Khan Burki (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 21, 2020 Category: Endocrinology Source Type: research

DIY artificial pancreas systems: the clinician perspective
Publication date: March 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 3Author(s): Emma G Wilmot, Thomas Danne (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 19, 2020 Category: Endocrinology Source Type: research

Health-care professional opinions of DIY artificial pancreas systems in the UK
Publication date: March 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 3Author(s): Thomas S J Crabtree, Pratik Choudhary, Peter Hammond, Alistair Lumb, Alasdair McLay, Emma G Wilmot (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 19, 2020 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2019; 7: 776–85
Publication date: March 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 3Author(s): (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 19, 2020 Category: Endocrinology Source Type: research

Testosterone: An Unauthorized Biography, Rebecca M Jordan-Young, Katrina Karkazis. Harvard University Press (2019), 288, £23·95, ISBN: 978-0674725324
Publication date: March 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 3Author(s): Robert Stirrups (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 19, 2020 Category: Endocrinology Source Type: research

Pyrethroid exposure: not so harmless after all
Publication date: Available online 14 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Barbara Demeneix, Michelle Leemans, Stephan Couderq (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 15, 2020 Category: Endocrinology Source Type: research

Metabolic surgery: one size fits all?
Publication date: Available online 11 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Bengt Novik (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 13, 2020 Category: Endocrinology Source Type: research

Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone
Publication date: Available online 11 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Pedro Marques, Natasha M Appelman-Dijkstra, Hans Gelderblom, Mark C Kruit, Wouter R van Furth, Alberto M Pereira, Nienke R Biermasz (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 13, 2020 Category: Endocrinology Source Type: research

Metabolic surgery: one size fits all? – Authors' reply
Publication date: Available online 11 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Jøran Hjelmesæth, Farhat Fatima, Kåre Inge Birkeland, Marius Svanevik, Dag Hofsø (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 13, 2020 Category: Endocrinology Source Type: research

Methimazole and risk of acute pancreatitis
Publication date: Available online 5 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Thomas H Brix, Lars C Lund, Daniel P Henriksen, Lars Folkestad, Steen J Bonnema, Jesper Hallas, Laszlo Hegedüs (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 6, 2020 Category: Endocrinology Source Type: research

Latent autoimmune diabetes of adulthood: time to take action
Publication date: Available online 4 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Didac Mauricio (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 5, 2020 Category: Endocrinology Source Type: research

Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
We examined the long-term risk of microvascular complications in people enrolled in the UK Prospective Diabetes Study (UKPDS), according to their diabetes autoimmunity status.MethodsWe did a post-hoc analysis of 30-year follow-up data from UKPDS (UKPDS 86). UKPDS participants with diabetes autoantibody measurements available and without previous microvascular events were included. Participants with at least one detectable autoantibody were identified as having latent autoimmune diabetes, and those who tested negative for all autoantibodies were identified as having type 2 diabetes. The incidence of the primary composite mi...
Source: The Lancet Diabetes and Endocrinology - February 5, 2020 Category: Endocrinology Source Type: research

Adolescent obesity and midlife cancer risk: a population-based cohort study of 2·3 million adolescents in Israel
We examined associations between measured body-mass index (BMI) at age 17 years and cancer incidence, and with mortality among those who developed cancer.MethodsIn a nationwide, population-based cohort of adolescents, height and weight were measured at pre-recruitment mandatory medical examination during 1967–2010. BMI was classified according to US Center for Disease Control and Prevention percentiles. We applied Cox proportional hazard models to estimate the hazard ratios (HRs) and 95% CIs for incident cases of cancer using the 5th–49th BMI percentile group as a reference. The primary outcome was any cancer d...
Source: The Lancet Diabetes and Endocrinology - February 4, 2020 Category: Endocrinology Source Type: research

Obesity in adolescents and cancer risk: causal relationship or epiphenomenon?
Publication date: Available online 3 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Thomas Reinehr (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 4, 2020 Category: Endocrinology Source Type: research

The obesity–cancer link: of increasing concern
Publication date: Available online 4 February 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - February 4, 2020 Category: Endocrinology Source Type: research

Evidence-based prescribing of diabetes medications: are we getting closer?
Publication date: Available online 29 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Srikanth Bellary, Abd A Tahrani, Anthony H Barnett (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 30, 2020 Category: Endocrinology Source Type: research

Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map
We examined the association between glucose-lowering medications and a broad range of cardiovascular outcomes, and assessed the strength of evidence for these associations.MethodsFor this umbrella review we searched PubMed, Embase, and the Cochrane Library to identify systematic reviews and meta-analyses of randomised controlled trials examining the cardiovascular safety of glucose-lowering medications. Cardiovascular outcomes examined included major adverse cardiovascular events, cardiovascular death, myocardial infarction, stroke, heart failure, unstable angina, and atrial fibrillation. For each meta-analysis, we estimat...
Source: The Lancet Diabetes and Endocrinology - January 30, 2020 Category: Endocrinology Source Type: research

Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes
Publication date: Available online 29 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Gordon C Weir, Jason Gaglia, Susan Bonner-WeirSummaryFor patients with type 1 diabetes, it is accepted among the scientific community that there is a marked reduction in β-cell mass; however, with type 2 diabetes, there is disagreement as to whether this reduction in mass occurs in every case. Some have argued that β-cell mass in some patients with type 2 diabetes is normal and that the cause of the hyperglycaemia in these patients is a functional abnormality of insulin secretion. In this Personal View, we ...
Source: The Lancet Diabetes and Endocrinology - January 30, 2020 Category: Endocrinology Source Type: research

Variation in the classification of hyperglycaemia in pregnancy and its implication
Publication date: Available online 28 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Yashdeep Gupta, Alpesh Goyal, Sanjay Kalra, Nikhil Tandon (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 29, 2020 Category: Endocrinology Source Type: research

Type 1 diabetes—early life origins and changing epidemiology
Publication date: Available online 27 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Jill M Norris, Randi K Johnson, Lars C SteneSummaryType 1 diabetes is a chronic, immune-mediated disease characterised by the destruction of insulin-producing cells. Standardised registry data show that type 1 diabetes incidence has increased 3–4% over the past three decades, supporting the role of environmental factors. Although several factors have been associated with type 1 diabetes, none of the associations are of a magnitude that could explain the rapid increase in incidence alone. Moreover, evidence of c...
Source: The Lancet Diabetes and Endocrinology - January 28, 2020 Category: Endocrinology Source Type: research

Forced migration and foot care in people with diabetes – Author's reply
Publication date: February 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 2Author(s): Sylvia Kehlenbrink, Philippa Boulle (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 22, 2020 Category: Endocrinology Source Type: research

Correction to Lancet Diabetes Endocrinol 2020; 8: 4–5
Publication date: February 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 2Author(s): (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 22, 2020 Category: Endocrinology Source Type: research

Forced migration and foot care in people with diabetes
Publication date: February 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 2Author(s): Arsene F Hobabagabo, Anne E Sumner (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 22, 2020 Category: Endocrinology Source Type: research

Estimands in diabetes clinical trials
Publication date: Available online 21 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Thinzar Min, Stephen C Bain (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 21, 2020 Category: Endocrinology Source Type: research

Alcohol and illicit drug use in people with diabetes
We describe evidence for substance use as a risk factor for new-onset diabetes, prevalence of use in people with diabetes, evidence linking substance use with diabetes-related health outcomes, and evidence on the management of these co-occurring conditions. (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 18, 2020 Category: Endocrinology Source Type: research

Tackling obesity in 2020—with a great resolution comes shared responsibility
Publication date: Available online 9 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 10, 2020 Category: Endocrinology Source Type: research

Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study
Publication date: Available online 7 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Gang Liu, Yang Hu, Geng Zong, An Pan, JoAnn E Manson, Kathryn M Rexrode, Eric B Rimm, Frank B Hu, Qi SunSummaryBackgroundTo reduce their overall substantially increased risk of cardiovascular disease and premature mortality, smoking cessation is especially important for people with diabetes. However, the effect of weight change after quitting smoking on the long-term health consequences of smoking cessation is unclear. We aimed to examine smoking cessation and subsequent weight change in relation to incident cardiovas...
Source: The Lancet Diabetes and Endocrinology - January 9, 2020 Category: Endocrinology Source Type: research

Approach to patients with hypophosphataemia
Publication date: Available online 7 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Pablo Florenzano, Cristiana Cipriani, Kelly L Roszko, Seiji Fukumoto, Michael T Collins, Salvatore Minisola, Jessica PepeSummaryPhosphate metabolism is an evolving area of basic and clinical research. In the past 15 years, knowledge on disturbances of phosphate homoeostasis has expanded, as has the discovery of new targeted therapies. Hypophosphataemia might be the biochemical finding in several diseases, and its clinical evaluation should initially focus on the assessment of pathophysiological mechanisms leading to l...
Source: The Lancet Diabetes and Endocrinology - January 9, 2020 Category: Endocrinology Source Type: research

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial
Publication date: Available online 7 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Hertzel C Gerstein, Robert Hart, Helen M Colhoun, Rafael Diaz, Mark Lakshmanan, Fady T Botros, Jeffrey Probstfield, Matthew C Riddle, Lars Rydén, Charles Messan Atisso, Leanne Dyal, Stephanie Hall, Alvaro Avezum, Jan Basile, Ignacio Conget, William C Cushman, Nicolae Hancu, Markolf Hanefeld, Petr Jansky, Matyas KeltaiSummaryBackgroundCardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) receptor agonists might reduce strokes. We analysed the effect of dulaglutide on stroke within the...
Source: The Lancet Diabetes and Endocrinology - January 9, 2020 Category: Endocrinology Source Type: research

REWIND to fast forward: time to revisit stroke prevention in type 2 diabetes?
Publication date: Available online 7 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Vanita Aroda (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 9, 2020 Category: Endocrinology Source Type: research

Smoking cessation, weight gain, and cardiovascular risk
Publication date: Available online 7 January 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Katarina Kos (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - January 9, 2020 Category: Endocrinology Source Type: research

Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study
Publication date: Available online 23 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Tiange Wang, Jieli Lu, Lixin Shi, Gang Chen, Min Xu, Yu Xu, Qing Su, Yiming Mu, Lulu Chen, Ruying Hu, Xulei Tang, Xuefeng Yu, Mian Li, Zhiyun Zhao, Yuhong Chen, Li Yan, Guijun Qin, Qin Wan, Meng Dai, Di ZhangSummaryBackgroundNational investigations on the interaction of insulin resistance, β-cell dysfunction, and obesity with the development of diabetes are scarce in China. We aimed to investigate the individual and joint associations of insulin resistance and β-cell dysfunction with incident diabetes, and...
Source: The Lancet Diabetes and Endocrinology - December 24, 2019 Category: Endocrinology Source Type: research

Insulin resistance versus β-cell dysfunction in type 2 diabetes: where public and personalised health meet
Publication date: Available online 23 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Elaine Y K Chow, Juliana C N Chan (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 24, 2019 Category: Endocrinology Source Type: research

The causal influence of maternal obesity on preterm birth
Publication date: Available online 20 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Christoph F Kurz, Adriana N König (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 21, 2019 Category: Endocrinology Source Type: research

Professional mode flash glucose monitoring in type 2 diabetes
Publication date: January 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 1Author(s): Norbert Hermanns, Dominic Ehrmann, Bernhard Kulzer (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 18, 2019 Category: Endocrinology Source Type: research

SGLT2 inhibitors to prevent diabetic kidney disease
Publication date: January 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 1Author(s): Paola Fioretto, Roberto Vettor, Roberto Pontremoli (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 18, 2019 Category: Endocrinology Source Type: research

LDL cholesterol: lower, faster, younger?
Publication date: January 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 1Author(s): Amanda J Berberich, Robert A Hegele (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 18, 2019 Category: Endocrinology Source Type: research

Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
Publication date: January 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 1Author(s): John Furler, David O'Neal, Jane Speight, Irene Blackberry, Jo-Anne Manski-Nankervis, Sharmala Thuraisingam, Katie de La Rue, Louise Ginnivan, Rebecca Doyle, Elizabeth Holmes-Truscott, Kamlesh Khunti, Kim Dalziel, Jason Chiang, Ralph Audehm, Mark Kennedy, Malcolm Clark, Alicia Jenkins, Amelia J Lake, Andrzej S Januszewski, Max CatchpoolSummaryBackgroundContinuous glucose monitoring, either real-time (personal) or retrospective (professional mode), can identify day-to-day glucose profiles to guide management decisions f...
Source: The Lancet Diabetes and Endocrinology - December 18, 2019 Category: Endocrinology Source Type: research

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
Publication date: January 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 1Author(s): Hiddo J L Heerspink, Avraham Karasik, Marcus Thuresson, Cheli Melzer-Cohen, Gabriel Chodick, Kamlesh Khunti, John P H Wilding, Luis Alberto Garcia Rodriguez, Lucia Cea-Soriano, Shun Kohsaka, Antonio Nicolucci, Giuseppe Lucisano, Fang-Ju Lin, Chih-Yuan Wang, Eric Wittbrodt, Peter Fenici, Mikhail KosiborodSummaryBackgroundCardiovascular and kidney outcome trials have shown that sodium-glucose co-transporter-2 (SGLT2) inhibitors slow progression of chronic kidney disease in patients with type 2 diabetes with or without c...
Source: The Lancet Diabetes and Endocrinology - December 18, 2019 Category: Endocrinology Source Type: research

Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants
Publication date: January 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 1Author(s): Nelson Wang, Jordan Fulcher, Nishan Abeysuriya, Laura Park, Shejil Kumar, Gian Luca Di Tanna, Ian Wilcox, Anthony Keech, Anthony Rodgers, Sean LalSummaryBackgroundThe benefits of LDL cholesterol-lowering treatment for the prevention of atherosclerotic cardiovascular disease are well established. However, the extent to which these effects differ by baseline LDL cholesterol, atherosclerotic cardiovascular disease risk, and the presence of comorbidities remains uncertain.MethodsWe did a systematic literature search (MEDL...
Source: The Lancet Diabetes and Endocrinology - December 18, 2019 Category: Endocrinology Source Type: research

Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk
Publication date: Available online 13 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Clifford J Bailey (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 15, 2019 Category: Endocrinology Source Type: research

Helena Teede: driving collaboration and impact
Publication date: Available online 12 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Tony Kirby (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 13, 2019 Category: Endocrinology Source Type: research

BPA: have flawed analytical techniques compromised risk assessments?
Publication date: Available online 5 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Roy Gerona, Frederick S vom Saal, Patricia A Hunt (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 6, 2019 Category: Endocrinology Source Type: research

Action on improving access to insulin
Publication date: Available online 5 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): The Lancet Diabetes & Endocrinology (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 6, 2019 Category: Endocrinology Source Type: research

Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis
Publication date: Available online 2 December 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Richeek Pradhan, François Montastruc, Vanessa Rousseau, Elisabetta Patorno, Laurent Azoulay (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - December 3, 2019 Category: Endocrinology Source Type: research

Iodine and folate—essential for mothers to be
Publication date: Available online 27 November 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Malcolm Prentice, Janis Hickey, Mark Vanderpump, Peter N Taylor, John H Lazarus (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - November 29, 2019 Category: Endocrinology Source Type: research

Liberalisation, deintensification, and simplification in diabetes management: words matter
Publication date: Available online 25 November 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Medha Munshi, Joshua J Neumiller (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - November 26, 2019 Category: Endocrinology Source Type: research

Physical activity and skeletal health in adults
Publication date: Available online 20 November 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Jane A Cauley, Lora GiangregorioSummaryThe purpose of this Review is to examine the associations between physical activity and skeletal health, with an emphasis on observational studies with fracture outcomes and randomised controlled trials (RCTs) of physical activity interventions in adults older than 40 years. In general, increased physical activity—primarily leisure time activity or moderate or vigorous physical activity—is associated with a 1–40% lower risk of hip and all fractures. The primar...
Source: The Lancet Diabetes and Endocrinology - November 21, 2019 Category: Endocrinology Source Type: research

Reducing the treatment gap in osteoporosis
Publication date: Available online 19 November 2019Source: The Lancet Diabetes & EndocrinologyAuthor(s): Juliet Compston (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - November 21, 2019 Category: Endocrinology Source Type: research

ADDITION-Europe: the first decade and beyond
Publication date: December 2019Source: The Lancet Diabetes & Endocrinology, Volume 7, Issue 12Author(s): Takayoshi Sasako, Takashi Kadowaki, Kohjiro Ueki (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - November 21, 2019 Category: Endocrinology Source Type: research